Michael Pichichero

Affiliations: 
2009- Rochester General Hospital 
Google:
"Michael Pichichero"
Mean distance: 39813
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kaur R, Schulz S, Sherman A, et al. (2024) Anticipated Effects of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media. The Pediatric Infectious Disease Journal
Pichichero ME. (2023) Variability of vaccine responsiveness in early life. Cellular Immunology. 104777
Shaffer M, Best K, Tang C, et al. (2023) Very early life microbiome and metabolome correlates with primary vaccination variability in children. Msystems. e0066123
Kaur R, Mangiafesto J, Pryharski K, et al. (2023) Expression conditions and characterization of a novelly-constructed lipoprotein intended as a vaccine to prevent human Haemophilus influenzae infections. The Journal of Biological Chemistry. 105031
Pichichero M, Malley R, Kaur R, et al. (2022) Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines. Expert Review of Vaccines. 22: 118-138
Michel LV, Kaur R, Gleghorn ML, et al. (2022) Haemophilus influenzae Protein D antibody suppression in a multi-component vaccine formulation. Febs Open Bio
Jones SP, Cook KH, Holmquist ML, et al. (2022) Vaccine target and carrier molecule nontypeable Haemophilus influenzae protein D dimerizes like the close Escherichia coli GlpQ homolog but unlike other known homolog dimers. Proteins
Chapman TJ, Pham M, Bajorski P, et al. (2022) Antibiotic Use and Vaccine Antibody Levels. Pediatrics. 149
Kaur R, Pichichero M. (2022) Lipidation of Antigens P6 and OMP26 Improves Immunogenicity and Protection against Nasopharyngeal Colonization and Ear Infection. Infection and Immunity. e0067821
Michel LV, Gallardo L, Konovalova A, et al. (2020) Ampicillin triggers the release of Pal in toxic vesicles from Escherichia coli. International Journal of Antimicrobial Agents. 106163
See more...